NEW YORK (GenomeWeb) – Trovagene said today it has closed a public offering of its common stock that brought in approximately $40.3 million in gross proceeds.

The company sold 4.6 million shares, including 600,000 shares issued when the offering's underwriters exercised their full overallotment option. The offering price was $8.75 per share, Trovagene said. The firm plans to use net proceeds for research and development, working capital, and to support other general corporate activities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.